EMV Capital (Acquired) Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Professionals
-
13
- Investments
-
25
- Exits
-
19
EMV Capital (Acquired) General Information
Company Description
Founded in 2018, EMV Capital was a venture capital firm based in London, United Kingdom. The firm sought to invest in early-stage, high-growth deep tech companies in the UK's life science, sustainability, and industrial sectors and internationally. On August 25, 2020, the firm was acquired by EMV Capital.
Business Details
Year Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 2nd Floor, 25-28 Old Burlington Street
- London W1S 3AN
- England, United Kingdom
EMV Capital (Acquired) Investments & Acquisitions (25)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AMR Bio | 29-Sep-2025 | Early Stage VC | Drug Delivery | Pre-Clinical Trials | ||
| ProAxsis | 07-Jul-2025 | Diagnostic Equipment | Generating Revenue | |||
| Martlet Capital | 13-May-2024 | Private Equity | Generating Revenue | |||
| Glycotest | 23-Jan-2024 | Biotechnology | Generating Revenue | |||
| QuantalX | 01-Jan-2024 | Diagnostic Equipment | Generating Revenue | |||
| Ventive (Building Products) | 06-Nov-2023 | Building Products | Generating Revenue | |||
| DName-iT | 30-Jun-2023 | Laboratory Services (Healthcare) | Generating Revenue | |||
| EpiBone | 27-Dec-2022 | Biotechnology | Clinical Trials - Phase 2 | |||
| Fox biosystems | 13-Dec-2022 | Later Stage VC | Other Devices and Supplies | Bankruptcy: Liquidation | ||
| Ventive (Building Products) | 20-Oct-2022 | Later Stage VC | Building Products | Generating Revenue |
EMV Capital (Acquired) Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Sofant Technologies | 04-Jul-2026 | Later Stage VC | |
| EpiBone | 24-Oct-2025 | ||
| Fox biosystems | 01-Jan-2025 | ||
| SageTech Medical | 06-Dec-2024 | ||
| Bimaplan | 23-Oct-2023 | ||
| G-Tech Medical | 10-Jul-2023 | ||
| Autorose | 04-Aug-2022 | ||
| Insight (Electronic Equipment and Instruments) | 01-Dec-2021 | ||
| Nanotech Industrial Solutions | 01-Dec-2021 | Later Stage VC | |
| Recycling Technologies | 01-Dec-2021 | IPO |
EMV Capital (Acquired) Investments by Industry, Year, and Region
EMV Capital (Acquired) Co-Investors (15)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| EMV Capital | 4 |
|
|
||
| KU Leuven Research & Development |
|
|
|||
| BNP Paribas |
|
|
|||
| KBC Group |
|
|
|||
| TCA Venture Group |
|
|
EMV Capital (Acquired) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Martlet Capital | Cambridge, United Kingdom | 2011 |
EMV Capital (Acquired) FAQs
-
What is EMV Capital (Acquired)?
Founded in 2018, EMV Capital was a venture capital firm based in London, United Kingdom.
-
When was EMV Capital (Acquired) founded?
EMV Capital (Acquired) was founded in 2018.
-
Where is EMV Capital (Acquired) headquartered?
EMV Capital (Acquired) is headquartered in London, United Kingdom.
-
How many investments has EMV Capital (Acquired) made?
EMV Capital (Acquired) has made 25 investments.
-
What has EMV Capital (Acquired) invested in?
EMV Capital (Acquired) has made numerous investments in companies like AMR Bio, ProAxsis, and Martlet Capital within the Drug Delivery, Diagnostic Equipment, and Private Equity industries.
-
What has EMV Capital (Acquired) invested in recently?
EMV Capital (Acquired)'s latest investment was on 29-Sep-2025 in AMR Bio, a company within the Drug Delivery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process